The correlation of stage and pathology of prostate cancer in Japan

International Journal of Urology

Volumn 7, Issue 4, 2000, Pages 139-144

  Kubota, Yutaka ^a,c   Imai, Kyoichi ^b   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Atagawa Onsen Hospital   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Cancer stage; Mass screening; Pathology; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; CORRELATION FUNCTION; EARLY DIAGNOSIS; HUMAN; JAPAN; MALE; MASS SCREENING; PATHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0033994084     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2000.00156.x     Document Type: Article

References (18)

1. 1 Spanos WJ, King. A, Keeney E, Wagner R, Slater JM. Age as prognostic factor in carcinoma of the cervix. Gynecol. Oncol. 1989; 35: 66-8.
2. 2 Kurl EJ, Peter LA, Vandenbroucke JP, Vrede A, van Kanten RW, Fleuren GJ. Cervical carcinoma in Surinam. Incidence and staging cervical carcinoma between 1989 and 1994. Cancer 1996; 77: 1329-33.
3. 3 Fisher CJ, Egan MK, Smith P, Wicks KM, Ills RR, Fentiman IS. Histopathology of breast cancer in relation to age. Br. J. Cancer 1997; 75: 593-6.
4. 4 Slattery LM, Friedman GD, Potter JD, Edwards S, Caan BJ, Samowitz W. A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer 1996; 78: 1666-70.
5. 5 Carter HB, Coffey DS. The prostate: An increasing medical problem. Prostate 1990; 16: 39-48.
6. 6 Imai K, Suzuki T, Kumasaka H et al. for the Gunma Urological Oncology Study Group. The mass screening for prostate cancer and the age eligibility. Nippon Hinyoukika Gakkai Zasshi 1996; 87: 1191-6.
7. 7 Watanabe H, Kojima M, Nakagawa S. Progression of prostate cancer in relation to age in patients detected by mass screening program. Tohoku J. Exp. Med. 1998; 184: 61-5.
8. 8 Imai K, Zinbo S, Shimizu K, Yamanaka H, Kumasaka F, Sato J. Clinical characteristics of prostatic cancer detected by mass screening. Prostate 1988; 12: 199-207.
9. 9 Imai K, Ichinose Y, Kubota Y, Yamanaka H, Sato J. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. J. Urol. 1995; 154: 1085-9.
10. 10 Imai K, Takahashi Y, Nakata S, Karr JP, Huben R. A comparison of prostate cancer patients in Japan and the USA. Int. J. Urol. 1994; 1: 256-62.
11. 11 Japanese Urological Association and the Japanese Pathological Society. General Rules for Clinical and Pathological Studies on Prostate Cancer, 2nd edn. Kanehara Shuppan, Tokyo, 1992 (in Japanese).
12. 12 Yatani R, Shiraishi T, Akazaki K, Hayashi T, Heilburn LK, Stemmermann GN. Incidental prostatic carcinoma: Morphmetry correlated with histological grade. Virchow Arch. 1986; 409: 395-405.
13. 13 McNeal JE, Bostwick DG, Kindrachuk A, Redwine EA, Freiha FS, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986; 11: 60-3.
14. 14 Schmid HP, McNeal JE, Stamey TA. Observations on the doubling time of the prostate cancer. Cancer 1993; 71: 2031-40.
15. 15 Schmid HP, Stamey TA, McNeal JE, Freiha FS, Redwine EA, Whittemore AS. Effect of the natural history on management of adenocarcinoma of the prostate. Urologe A 1994; 33: 144-8.
16. 16 Pearson JD, Carter HB. Natural history of changes in prostate specific antigen in early stage prostate cancer. J. Urol. 1994; 152: 1743-8.
17. 17 Jacobsen SJ, Katusic SK, Bergstralha EJ et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 1998; 274: 1445-9.
18. 18 Catalona WJ, Smith DS, Ratliff TL, Baster JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993; 270: 948-54.